Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
European Journal of Clinical Pharmacology|April 24, 2014
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancerNiels Eckstein, Bodo HaasDiabetology & Metabolic Syndrome|October 30, 2012
Targeting adipose tissueBodo Haas, Paul Schlinkert, Peter Mayer, et al.International Journal of Molecular Sciences|September 26, 2020
Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma CellsBernd Kaina, Lea Beltzig, Andrea Piee-Staffa, et al.Regulatory Toxicology and Pharmacology : RTP|March 1, 2016
Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissuesBodo Haas, Konstantin Weber-Lassalle, Roland Frötschl, et al.Orphanet Journal of Rare Diseases|August 6, 2014
Systemic therapy of Cushing's syndromeNiels Eckstein, Bodo Haas, Moritz David Sebastian Hass, et al.Methods in Molecular Biology (Clifton, N.J.)|May 28, 2013
Analysis of cGMP signaling in adipocytesKatja Jennissen, Bodo Haas, Michaela M Mitschke, et al.Journal of Cancer Research and Clinical Oncology|December 14, 2020
Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependentBodo Haas, Janine Ciftcioglu, Sanja Jermar, et al.Molecular Metabolism|August 13, 2015
A novel crosstalk between Alk7 and cGMP signaling differentially regulates brown adipocyte functionAileen Balkow, Johanna Jagow, Bodo Haas, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 24, 2025
Apoptotic and senolytic effects of hERG/Eag1 channel blockers in combination with temozolomide in human glioblastoma cellsBodo Haas, Inken Roth, Luisa Säcker, et al.International Journal of Molecular Sciences|September 26, 2018
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma CellsBodo Haas, Lena Schütte, Maria Wos-Maganga, et al.Pageof 3